REVIVO Biosystems Pte. Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
REVIVO Biosystems Pte. Ltd - overview
Established
2019
Location
Singapore, -, Singapore
Primary Industry
Biotechnology
About
Based in Singapore, and founded in 2019 by Bert Grobben, Massimo Alberti, Sriram Gopu, and Zhiping Wang, REVIVO Biosystems Pte. Ltd develops technology that uses a realistic 4D model of human skin for the testing of chemical, cosmetic, and pharmaceutical research labs. In November 2021, REVIVO Biosystems Pte. Ltd raised an undisclosed amount of venture funding from Evonik Venture Capital.
Mr. Massimo Alberti is the CEO of REVIVO Biosystems Pte. Ltd. REVIVO Biosystems provides technology and services for in vitro and ex vivo testing of chemicals, cosmetic formulations, ingredients, and therapeutics.
The company also offers a platform that automates the testing procedure ex vivo and in vitro screening on epithelial tissue models. In addition, REVIVO provides proprietary 4D human skin models with multiple properties, including barrier property, subcutaneous blood flow, full-thickness & morphology, and viable skin for up to 21 days. The company offers an alternative to animal testing, which is cost-efficient, reliable, and quicker. The company’s major customers are cosmetic manufacturers, pharma and biotech, academic labs, CROs, and ingredient providers.
REVIVO Biosystems Pte. Ltd plans to use its proceeds from November 2021 funding to support the development and commercialization of a realistic 4D model of human skin that provides an alternative to animal testing.
Current Investors
SGInnovate, Evonik Venture Capital, B7 Capital
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Website
www.revivobio.com
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.